Nutritional assessment and lipid profile in HIV-infected children and adolescents treated with highly active antiretroviral therapy

Tremeschin, Marina Hjertquist; Sartorelli, Daniela Saes; Cervi, Maria Célia; Negrini, Bento Vidal de Moura; Salomão, Roberta Garcia; Monteiro, Jacqueline Pontes.
Rev. Soc. Bras. Med. Trop ; 44(3): 274-281, May-June 2011. tab
Artigo em Inglês | LILACS | ID: lil-593364

Documentos relacionados

  1. Advanced molecular mechanisms of modified DRV compounds in targeting HIV-1 protease mutations and interrupting monomer dimerization.
  2. Nutritional assessment and lipid profile in HIV-infected children and adolescents treated with highly active antiretroviral therapy.
  3. Design and Evaluation of Novel HIV-1 Protease Inhibitors Containing Phenols or Polyphenols as P2 Ligands with High Activity against DRV-Resistant HIV-1 Variants.
  4. Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial.
  5. Evolving Mutational Buildup in HIV-1 Protease Shifts Conformational Dynamics to Gain Drug Resistance.
  6. Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors <i>In Vitro</i>.
  7. The Chiron Approach to (3<i>R</i>,3<i>aS</i>,6<i>aR</i>)-Hexahydrofuro[2,3-<i>b</i>]furan-3-ol, a Key Subunit of HIV-1 Protease Inhibitor Drug, Darunavir.
  8. Elasticity-Associated Functionality and Inhibition of the HIV Protease.
  9. A kind of HIV-1 protease inhibitors containing phenols with antiviral activity against DRV-resistant variants.
  10. Machine learning-guided design of potent darunavir analogs targeting HIV-1 proteases: A computational approach for antiretroviral drug discovery.